Syneos Health Stock Tanks After Q2 Sales Miss, FY22 Outlook Cut Citing Macro Economic Trends
Syneos Health Inc’s (NASDAQ:SYNH) Q2 revenue increased 6.1% on a reported basis and 8.3% on a constant currency (CC)…
IDEXX Laboratories Misses on Q2 Earnings, Issues FY22 Guidance Below Consensus
IDEXX Laboratories Inc (NASDAQ:IDXX) reported Q2 revenues of $861 million, an increase of 4% Y/Y on a reported basis and…
Conformis Shares Jump On Personalized Orthopedic Implants Contract
Conformis Inc (NASDAQ:CFMS) entered into a multi-year agreement with Vizient Inc to offer personalized orthopedic implants to Vizient’s membership of healthcare facilities. The…
AbbVie, Sosei Build In 2020 Pact With New Neurological Disease-Focused Agreement
Sosei Group Corporation and AbbVie Inc (NYSE:ABBV) announced a new drug discovery collaboration and option-to-license agreement to discover, develop and commercialize small molecules…
Recap Of Monday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application…
Aerie Shares Gain Following Patient Dosing In Late-Stage Dry Eye Disease Study
Aerie Pharmaceuticals (NASDAQ: AERI) has initiated patient dosing in the Phase 3 registrational COMET-3 study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease (DED).
Acadia Healthcare Earns 12% Price Target Bump ‘On Strong Q2’
RBC Capital Markets raised the price target on Acadia Healthcare Company Inc (NASDAQ:ACHC) to $94 from $84 with an Outperform rating unchanged.…
‘Novel Approach For Retinal Disease Needs’ Stock Belite Bio Has 70% Potential Upside According To This Analyst
HC Wainwright initiated coverage on Belite Bio Inc (NASDAQ:BLTE) with a Buy rating and price target of $58 per ADS. Belite Bio…
Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care and biotech stocks on the move.
Stealth BioTherapeutics Enters Going Private Agreement
Stealth BioTherapeutics Corp (NASDAQ:MITO) will be acquired by a consortium of investors led by Morningside Venture (I) Investments Ltd and J.…